ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

FBIO Fortress Biotech Inc

1.70
-0.02 (-1.16%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fortress Biotech Inc FBIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -1.16% 1.70 18:50:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.71 1.70 1.79 1.72 1.72
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202407:30GLOBEJourney Medical Corporation to Present at the Planet..
24/4/202406:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
28/3/202415:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
28/3/202408:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
25/3/202407:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
21/3/202415:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/3/202415:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
18/3/202407:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/3/202407:30GLOBEJourney Medical Corporation to Announce Year End 2023..
15/3/202407:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
13/3/202407:30GLOBEJourney Medical Corporation to Participate in the 36th..
12/3/202407:30GLOBEFortress Biotech to Participate in 36th Annual ROTH..
11/3/202407:30GLOBEJourney Medical Corporation Announces Presentation of Data..
11/3/202407:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
07/3/202406:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
04/3/202407:30GLOBEFortress Biotech and Cyprium Therapeutics Announce $4.1..
22/2/202407:30GLOBEAvenue Therapeutics Announces Publication in Drug..
11/1/202407:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
11/1/202407:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
05/1/202408:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
05/1/202407:30GLOBEJourney Medical Corporation Submits New Drug Application to..
04/1/202407:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
03/1/202415:01GLOBEFortress Biotech Announces Closing of $11 Million Registered..
02/1/202415:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
02/1/202407:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
29/12/202307:20GLOBEFortress Biotech Announces Pricing of $11 Million Registered..
11/12/202307:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
06/12/202307:30GLOBECyprium Therapeutics, a Fortress Biotech Subsidiary Company,..
06/12/202307:30PRNUSSentynl Therapeutics Completes Asset Transfer of CUTX-101..
06/12/202307:00GLOBEJourney Medical Corporation Announces Successful Completion..
01/12/202307:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
14/11/202315:10GLOBEFortress Biotech Reports Third Quarter 2023 Financial..
14/11/202315:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
14/11/202315:01GLOBEFortress Biotech Announces Closing of $10.0 Million Public..
13/11/202315:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
10/11/202307:15GLOBEFortress Biotech Announces Pricing of $10.0 Million Public..
09/11/202316:05GLOBEFortress Biotech Announces Launch of Proposed Public..
07/11/202315:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..
02/11/202314:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202308:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
31/10/202308:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
31/10/202307:30GLOBEJourney Medical Corporation to Announce Third Quarter 2023..
30/10/202313:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
26/10/202311:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26/10/202308:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
20/10/202307:30GLOBEJourney Medical Corporation Announces Data from..
16/10/202308:00GLOBEFortress Biotech Subsidiary Helocyte Announces Option..
09/10/202311:50GLOBEFortress Biotech Announces Reverse Stock Split
05/10/202307:30GLOBEFortress Biotech to Present at ROTH MKM 2023 Healthcare..
07/9/202307:30GLOBEFortress Biotech to Present at H.C. Wainwright 25th Annual..

Su Consulta Reciente

Delayed Upgrade Clock